450 related articles for article (PubMed ID: 22097138)
1. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
2. [NSAIDs combined with radiotherapy to prevent heterotopic ossification after total hip arthroplasty].
Wu FF; Gao HL; Huang S; Wang GR; Jiang XS; Li JY; Shou ZQ
Zhongguo Gu Shang; 2018 Jun; 31(6):538-542. PubMed ID: 29945410
[TBL] [Abstract][Full Text] [Related]
3. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
4. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Pohl F; Seufert J; Tauscher A; Lehmann H; Springorum HW; Flentje M; Koelbl O
Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
[TBL] [Abstract][Full Text] [Related]
6. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
[TBL] [Abstract][Full Text] [Related]
7. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
Vasileiadis GI; Sakellariou VI; Kelekis A; Galanos A; Soucacos PN; Papagelopoulos PJ; Babis GC
J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):159-65. PubMed ID: 20516633
[TBL] [Abstract][Full Text] [Related]
8. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
Schara K; Herman S
Acta Chir Orthop Traumatol Cech; 2001; 68(2):105-8. PubMed ID: 11706718
[TBL] [Abstract][Full Text] [Related]
9. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification in patients after total hip replacement.
Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Legenstein R; Bösch P; Ungersböck A
Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
13. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
Heyd R; Strassmann G; Kirchner J; Schopohl B; Böttcher HD
Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
[TBL] [Abstract][Full Text] [Related]
14. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
van der Heide HJ; Koorevaar RC; Lemmens JA; van Kampen A; Schreurs BW
Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
[TBL] [Abstract][Full Text] [Related]
15. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
[TBL] [Abstract][Full Text] [Related]
17. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty.
Yutani Y; Ohashi H; Nishimura N; Yamano Y
Osaka City Med J; 1995 Dec; 41(2):63-73. PubMed ID: 8778647
[TBL] [Abstract][Full Text] [Related]
19. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]